Latest news
HARROW HEALTH Q2 2026 Earnings Preview: Recent $HROW Insider Trading, Hedge Fund Activity, and More - Quiver QuantitativeQuiver Quantitative · Sat, 08 Aug 2026 21:07:00 GMTHarrow (HROW) After The Pullback, Is Its Growth Story Still Undervalued - simplywall.stsimplywall.st · Sat, 08 Aug 2026 13:30:42 GMTHROW Looks 8.5% Undervalued on GF Value™ - GuruFocusGuruFocus · Sat, 08 Aug 2026 04:47:36 GMTDimensional Fund Advisors LP Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:44:46 GMTThe only FDA-approved dry-eye nasal spray is set to join Harrow later in 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTOpaleye Management (NASDAQ: HROW) discloses 6.44% Harrow ownership in latest filing - Stock TitanStock Titan · Fri, 31 Jul 2026 20:06:02 GMTDo Harrow’s (HROW) Retina Data Updates Quietly Redefine Its Core Growth Strategy? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 16:19:22 GMT